What is Koning?
Koning Health is at the forefront of breast imaging innovation, developing the Koning Vera Breast CT (KBCT). This groundbreaking technology provides high-resolution 3D imaging without the need for breast compression, a critical advancement for improving the early detection of breast cancer. The company's focus on enhancing diagnostic accuracy and patient comfort positions it as a key innovator, serving healthcare providers and women's health advocates. With a robust portfolio of over 120 patents and numerous industry accolades, Koning is dedicated to broadening the global accessibility of its transformative imaging solutions.
How much funding has Koning raised?
Koning has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Koning?
The recent large-scale, late-stage funding, characterized as a major strategic investment, signals Koning's transition into a scaling phase. This influx of capital is likely earmarked for expanding manufacturing capabilities, accelerating market adoption of the Vera Breast CT system, and potentially exploring new geographical markets. The company's strong intellectual property position and focus on a critical unmet need in cancer diagnostics suggest a trajectory aimed at solidifying its market leadership and driving significant growth in the coming years.
See full Koning company page
